; Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review

VIEWS: 206 PAGES: 25

Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights Sunovion Pharmaceuticals Inc. (Sunovion), formerly, Sepracor Inc., is a research- based pharmaceutical company. The company discovers, develops and commercializes therapeutic products that focus on the treatment of central nervous system and respiratory disorders. Its product portfolio includes xopenex inhalation solution, xopenex HFA Metered-Dose aerosol Inhaler (MDI), arformoterol tartrate inhalation solution, eszopiclone tablets, ciclesonide nasal spray and ciclesonide HFA inhalation aerosol. S

More Info
  • pg 1
									              Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review
        Reference Code: GDME287809SA                                                                                         Publication Date: FEB 2013

          84 Waterford Drive                                 Phone             +1 508 4816700                   Revenue         NA
          Marlborough, MA                                    Fax               +1 508 4817683                   Net Profit      NA
          01752                                              Website           www.sunovion.com                 Employees       NA
          United States                                      Exchange                                           Industry        Medical Equipment

       Company Overview
       Sunovion Pharmaceuticals Inc. (Sunovion), formerly, Sepracor Inc., is a research- based pharmaceutical company. The company
       discovers, develops and commercializes therapeutic products that focus on the treatment of central nervous system and
       respiratory disorders. Its product portfolio includes xopenex inhalation solution, xopenex HFA Metered-Dose aerosol Inhaler
       (MDI), arformoterol tartrate inhalation solution, eszopiclone tablets, ciclesonide nasal spray and ciclesonide HFA inhalation
       aerosol.
       Key Executives                                                             SWOT Analysis
                     Name                                Title                     Sunovion Pharmaceuticals Inc., SWOT Analysis
         Hiroshi Nomura                    Chief Financial Officer                 Strengths                            Weaknesses
         Antony Loebel                     Chief Medical Officer
                                                                                   Wide Product Portfolio               Patent Infringement Claims
         Richard Russell                   Chief Commercial Officer
                                                                                   New Acquistions
         Yoshiharu Ikeda                   Executive Vice President,
                                           - Corporate Strategy
         Robert Gregorio                   Senior Vice President, -                Opportunities                        Threats
                                           Human     Resources    &
                                           Administration                          New Product Development              Uncertain R&D Outcomes
        Source: Company Website, Primary and Secondary Research,                   Market for CNS Disorders &           Highly Competitive
        GlobalData
                                                                                   Respiratory Conditions               Environment

        Key Competitors
                                                                                  Source: Company Website, Primary and Secondary Research, GlobalData
         Teva Pharmaceuticals USA, Inc.
         Paladin Labs Inc.
         Aptalis Pharma Inc.
        GlaxoSmithKline plc
        Source: Company Website, Primary and Secondary Research,
        GlobalData


       Recent Developments

       Dec 05, 2012                  Sunovion Pharma To Cease Operations At Windsor, Nova Scotia Manufacturing Plant
       Source: Annual Report, Company Website, Primary and Secondary Research, GlobalData




Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review                                                                Reference Code: GDME287809SA
Source : www.globalcompanyintelligence.com                                                                                                              Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Sunovion Pharmaceuticals Inc. - Key Facts ....................................................................................................................................... 4
       Sunovion Pharmaceuticals Inc. - Key Employees .............................................................................................................................. 5
       Sunovion Pharmaceuticals Inc. - Key Employee Biographies ............................................................................................................ 6
       Sunovion Pharmaceuticals Inc. - Major Products and Services ......................................................................................................... 7
       Sunovion Pharmaceuticals Inc. - Pharmaceutical Pipeline Products Data ......................................................................................... 8
          Sunovion Pharmaceuticals Inc., Pipeline Products by Therapy Area ............................................................................................. 8
          Sunovion Pharmaceuticals Inc., Pipeline Products by Development Phase ................................................................................... 9
       Sunovion Pharmaceuticals Inc. - History .......................................................................................................................................... 10
       Sunovion Pharmaceuticals Inc. - Locations And Subsidiaries .......................................................................................................... 12
          Head Office ................................................................................................................................................................................... 12
          Other Locations & Subsidiaries ..................................................................................................................................................... 12
       Section 2 – Company Analysis ......................................................................................................................................................... 13
       Sunovion Pharmaceuticals Inc. - Business Description.................................................................................................................... 13
       Sunovion Pharmaceuticals Inc. - Corporate Strategy ....................................................................................................................... 14
       Sunovion Pharmaceuticals Inc. - SWOT Analysis ............................................................................................................................ 15
          SWOT Analysis - Overview...................................................................................
								
To top